UTAH MEDICAL PRODUCTS, INC. (UTMD) Operating margin 2016–2025
UTAH MEDICAL PRODUCTS, INC. (UTMD) operating margin by fiscal year — reported operating income divided by reported revenue.
29.6%FY2025 · since FY2016: 41.2% → 29.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 29.6% | -3.6 pp |
| FY2024 | 33.2% | -0.2 pp |
| FY2023 | 33.4% | -4.4 pp |
| FY2022 | 37.9% | -0.6 pp |
| FY2021 | 38.5% | +6.0 pp |
| FY2020 | 32.5% | -5.1 pp |
| FY2019 | 37.6% | -6.9 pp |
| FY2018 | 44.5% | -1.4 pp |
| FY2017 | 45.9% | +4.7 pp |
| FY2016 | 41.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More UTMD financial trends
UTMD RevenueUTMD Net incomeUTMD Net marginUTMD Gross profitUTMD Gross marginUTMD Operating incomeUTMD Operating cash flowUTMD Free cash flowUTMD Capital expendituresUTMD Return on equityUTMD Stock buybacksUTMD Dividends paidUTMD Total assetsUTMD Total liabilitiesUTMD Shareholders’ equityUTMD overview →